en
Scientific article
Open access
English

Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionals

Published inPLOS ONE, vol. 14, no. 10, e0223649
Publication date2019
Abstract

Hepatitis C virus (HCV) causes both acute and chronic infection, which can potentially develop into cirrhosis and liver cancer. Healthcare systems are struggling to finance costly direct-acting antiviral agents through public funding for uninsured patients, despite the unprecedented high cure rates of these agents. Vulnerable populations are at higher risk of HCV infection. The personal importation scheme is based on the legal right to import any unauthorized generics for personal use. This study was designed to assess the knowledge and perceptions of stakeholders on unauthorized generics.

Keywords
  • Adult
  • Drugs, Generic/therapeutic use
  • Female
  • Health Knowledge, Attitudes, Practice
  • Health Personnel
  • Hepatitis C/drug therapy
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Pharmacists
  • Physicians
  • Surveys and Questionnaires
  • Young Adult
Citation (ISO format)
GARCIA, Amandine et al. Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionals. In: PLOS ONE, 2019, vol. 14, n° 10, p. e0223649. doi: 10.1371/journal.pone.0223649
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1932-6203
196views
89downloads

Technical informations

Creation10/29/2020 4:49:00 PM
First validation10/29/2020 4:49:00 PM
Update time03/15/2023 11:34:08 PM
Status update03/15/2023 11:34:08 PM
Last indexation02/12/2024 11:59:05 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack